Search
-
Mastering complexity: The path towards a cancer-free reality
This is the third and final paper in a series which began eight years ago, focusing on unravelling – and ultimately overcoming – the sheer complexity of cancer, one of humanity’s oldest and most formidable foes.
-
Monitoring the obesity treatment revolution, in healthcare and beyond
Ipsos has launched three new syndicated studies to monitor and anticipate changes in the rapidly evolving landscape of obesity treatment.
-
Ipsos Update – November 2023
Health, trust, ESG… Ipsos Update explores the latest and greatest research & thinking on key topics from Ipsos teams around the world.
-
The omnichannel reality in the Pharmaceutical industry
The role of voice of the customer research and analytics in driving omnichannel success
-
Applying cultural transferability analysis to ESG
The three cultural dimensions that are shaping attitudes, perceptions and behaviour around ESG in the local markets
-
Oncology: the disease, dynamics & challenges of market research
The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved – from patients and their carers to cancer treaters to the companies who manufacture and market treatments.
-
Real-World Evidence (RWE) Centre of Expertise
The RWE Centre of Expertise, part of Ipsos’ global healthcare business, consolidates Ipsos’ extensive capabilities in capturing and analysing real-world data with our deep understanding of compliance and regulations to create robust real-world evidence, an area of increasing priority for healthcare companies.
-
Ipsos Update – May 2023
Generations, corporate purpose, climate change… Ipsos Update explores the latest and greatest research & thinking on key topics from Ipsos teams around the world.
-
Ipsos Update – March 2023
Advertising, love, healthcare… Ipsos Update explores the latest and greatest research & thinking on key topics from Ipsos teams around the world.
-
Annual results - Strong performance in an uncertain environment
Ipsos achieved a strong performance in 2022, with a record level of profitability, demonstrating the strength and relevance of its operating model.